Navigation Links
Mindray Announces First Quarter 2013 Financial Results
Date:5/6/2013

lion respectively.

As of March 31, 2013, the company had approximately 7,500 employees.

Business Outlook for Full Year 2013The company maintains its full year guidance and expects its full year 2013 net revenues to grow at least 17% over its full year 2012 net revenues.

The company continues to expect its full year 2013 non-GAAP net income to grow at least 15% over its non-GAAP net income for full year 2012. This guidance excludes the tax benefits of $19.4 million related to the National Key Software Enterprise status for the calendar year 2011 and 2012, which was recognized in the first quarter of 2013 and assumes a corporate income tax rate of 15% applicable to the Shenzhen subsidiary.

The company expects its capital expenditure for full year 2013 to be around $130 million.

The company's practice is to provide guidance on a full year basis only. This forecast reflects Mindray's current and preliminary views, which are subject to change.

"We are maintaining our guidance at this time," commented Mr. Li Xiting, Mindray's President and Chief Executive Officer. "For the rest of 2013, we expect China to be our primary growth engine, based on our strong market position and favorable macro healthcare spending trends. We are optimistic that the prospects for emerging markets should improve going forward. However, risk factors such as political and currency issues remain. We will closely monitor these factors and react promptly. In developed markets, as we stated earlier this year, we expect challenging conditions to continue due to economic and hospital spending uncertainties. However, we will maintain our long-term growth strategy in these countries. Going forward, we will continue to build a stronger global brand, improve our operational efficiency and seek attractive M&A and collaboration opportunities."

Conference Call InformationMindray's management will hold an earnings conference call at 8:00 AM on May 7, 201
'/>"/>

SOURCE Mindray Medical International Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Mindray to Report First Quarter 2013 Financial Results on May 6, 2013
2. Mindray Medical to Exhibit New Products at 69th China International Medical Equipment Fair
3. Mindray Announces 2012 Fourth Quarter and Full Year Results
4. Mindray to Report Fourth Quarter and Full Year 2012 Financial Results on February 25, 2013
5. Mindray to Hold Annual General Meeting in Hong Kong on December 28, 2012
6. Mindray to Showcase Enhancements to DC-8 Ultrasound System at RSNA
7. Mindray DS USA, Inc. has Initiated a Voluntary Recall Affecting the A3/A5 Anesthesia Delivery System
8. Mindray Medical Announces Top Management Change
9. Mindray Medical to Participate in MEDICA 2012 in Dusseldorf, Germany
10. Mindray Announces Second Quarter 2012 Financial Results
11. Mindray to Report Second Quarter 2012 Financial Results on August 6, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... , Aug. 28, 2014 Auxilium Pharmaceuticals, ... company, today announced that data from trials evaluating the use ... (DC) cords concurrently in adult patients with a palpable cord ... Meeting of the American Society for Surgery of the Hand ... September 18-20, 2014. XIAFLEX ® (CCH) is a biologic ...
(Date:8/28/2014)... , Aug. 28, 2014 Today is the ... mental health, higher education, student and pharmaceutical organizations that ... diversion of ADHD prescription stimulant medication. The Coalition will ... Although reported rates of nonmedical use vary, a ... 9.3 percent 1 of college students reported nonmedical ...
(Date:8/27/2014)... China, Aug. 28, 2014 China Nepstar ... or the "Company"), a leading retail drugstore chain ... operated stores, today announced its unaudited financial results ... Financial HighlightsFor the quarter ended June 30, 2014: ... million (US$110.7 million) compared to RMB638.8 million in the ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting 2Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting 3Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting 4Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting 5Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting 6New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications 2New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications 3New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications 4New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications 5New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications 6China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 2China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 3China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 4China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 5China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 6China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 7China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 8China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 9China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 10China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 11
... , NEW YORK, Nov. 20 ... report is available in its catalogue. , ... , http://www.reportlinker.com/p0164373/Pipettes--Pipettors---A-Global-Market-Perspective.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire , ... part of any research laboratory. Large-scale applications in ...
... , NATICK, Mass. and LONDON, ... BSX ) today announced that it has received 510(k) ... and CE Mark approval to market its WallFlex® Fully ... strictures (obstructions) caused by tumors in patients with resectable ...
Cached Medicine Technology:Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4
(Date:8/28/2014)... August 28, 2014 Postcard-worthy views, star-laden ... exclusive glamping by the beach in your own private ... del Palmar at the Islands of Loreto. , The ... an unforgettable experience in paradise with its romantic Honeymoon ... 8, 2014. , “Villa del Palmar at the Islands ...
(Date:8/28/2014)... San Diego, CA (PRWEB) August 28, 2014 ... age of 40 and are considered the leading cause of ... of the eye’s natural lens behind the iris, cataracts are ... year 2020, mostly due to an aging population. Cataracts are ... eye. Each year, Dr. Michael Tracy of Carlsbad Eye ...
(Date:8/28/2014)... A leading Florida mental health program ... a result of media coverage surrounding Robin Williams’ death. When ... ‘copycat suicides’ among the general public. The Sylvia Brafman Mental ... what happened—the suicide itself—but on what we can do to ... is a tragedy on so many counts,” said Ben Brafman, ...
(Date:8/28/2014)... Newport Beach, CA (PRWEB) August 28, 2014 ... barbecues, trips to the beach and those last glorious ... Sadati’s Orange County patients are planning on spending their ... , Dr. Kevin Sadati, a board certified facial plastic ... that this year patients have taken advantage of their ...
(Date:8/28/2014)... August 28, 2014 Bleeding gums are not ... or flossing, according to the prosthodontists at the Anacapa Dental ... some serious medical conditions, Dr. Saj Jivraj and Dr. Mamaly ... you are not properly cleaning your teeth all the way ... and bleed easily,” Dr. Jivraj said. , Despite their reputations ...
Breaking Medicine News(10 mins):Health News:Honeymoon in Paradise at Villa del Palmar at the Islands of Loreto 2Health News:Honeymoon in Paradise at Villa del Palmar at the Islands of Loreto 3Health News:Honeymoon in Paradise at Villa del Palmar at the Islands of Loreto 4Health News:Cataract Awareness Month an Opportunity to Focus on Vision Care and Ocular Health 2Health News:Sylvia Brafman Mental Health Center Warns of Suicide Contagion Following Robin Williams’ Death 2Health News:Newport Beach Facial Plastic Surgeon, Dr. Kevin Sadati Announces a Patient Trend of Scheduling Cosmetic Surgery Procedures over Long Holiday Weekends 2Health News:Newport Beach Facial Plastic Surgeon, Dr. Kevin Sadati Announces a Patient Trend of Scheduling Cosmetic Surgery Procedures over Long Holiday Weekends 3Health News:Newport Beach Facial Plastic Surgeon, Dr. Kevin Sadati Announces a Patient Trend of Scheduling Cosmetic Surgery Procedures over Long Holiday Weekends 4Health News:Elite Oxnard, Calif., Dentists Offer 4 Tips for Protecting Children’s Gums 2Health News:Elite Oxnard, Calif., Dentists Offer 4 Tips for Protecting Children’s Gums 3Health News:Elite Oxnard, Calif., Dentists Offer 4 Tips for Protecting Children’s Gums 4Health News:Elite Oxnard, Calif., Dentists Offer 4 Tips for Protecting Children’s Gums 5
... 2008 at 11:00 AM ET, LIVINGSTON, N.J., May ... recognized leader in advanced,injection technologies, today announced that the ... ended March 31, 2008 on Thursday,May 15, 2008., ... 2008, beginning,at 11:00 AM Eastern time, and invites all ...
... funding to PBTF Institute at Duke accelerates search for ... ... The Pediatric Brain,Tumor Foundation (PBTF) is giving an additional $6 million ... to $12 million., To view the Multimedia News Release, go ...
... for prehypertensive people in morning use, researchers report , , ... can control prehypertension, but only if it is taken ... taken every morning didn,t lower the blood pressure of ... C. Hermida reported Wednesday at the American Society of ...
... Del., May 14 AstraZeneca (NYSE:,AZN) today announced ... has,approved SEROQUEL(R) (quetiapine fumarate tablets) for the maintenance,treatment ... therapy to,lithium or divalproex. SEROQUEL is approved by ... also the only single agent approved by the ...
... AMRN ) today announced a private placement ... ("ADSs") with several new,institutional and accredited investors, and ... $60 million funded over two equal tranches., ... agreements for,gross proceeds of up to $56 million, ...
... Mass., and SYDNEY, Australia, May 14 /PRNewswire-FirstCall/,-- HeartWare Limited ... an investor presentation at the Seventh Annual JMP Securities ... Wednesday, May 21, 2008. The,conference is being held at ... webcast of the Company,s presentation at the conference will ...
Cached Medicine News:Health News:Milestone Scientific to Announce First Quarter 2008 Results on Thursday, May 15, 2008 2Health News:Video: Pediatric Brain Tumor Foundation Gives $6 Million Grant to Duke 2Health News:Aspirin at Bedtime Lowers Blood Pressure 2Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 2Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 3Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 4Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 5Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 6Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 7Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 8Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 9Health News:Amarin Announces Private Placement for up to $60 Million 2Health News:Amarin Announces Private Placement for up to $60 Million 3Health News:Amarin Announces Private Placement for up to $60 Million 4Health News:Amarin Announces Private Placement for up to $60 Million 5Health News:HeartWare to Present at Seventh Annual JMP Securities Research Conference 2
Quick Release Holder designed for the 8000 Series Microtome to hold hardboard squares....
... rotary retracting, self-lubricating design and has a heavy ... construction makes it accurate and incredibly reliable. ,The ... lateral motion is controlled and allows no slop ... lesser designs which can result in 'chatter' and ...
Allows for custom orientation of specimen...
Disposable Feather Blades, 50 per pack...
Medicine Products: